Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

People with alopecia areata have a higher risk of stroke.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Finasteride can cause sexual problems and depression in young men.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.